Thirty-Days versus Longer Duration of Dual Antiplatelet Treatment after Percutaneous Coronary Interventions with Newer Drug-Eluting Stents: A Systematic Review and Meta-Analysis

Thirty-Days versus Longer Duration of Dual Antiplatelet Treatment after Percutaneous Coronary Interventions with Newer Drug-Eluting Stents: A Systematic Review and Meta-Analysis

Abbreviation of the duration of dual antiplatelet therapy (DAPT) (one or three months) has been recently proposed, especially for high bleeding risk patients, after percutaneous coronary intervention (PCI) with drug-eluting stent (DES). Three databases were screened for eligible randomized control t...

Full description

Bibliographic Details
Main Authors: Grigorios Tsigkas, Anastasios Apostolos, David-Dimitrios Chlorogiannis, Elena Bousoula, Georgios Vasilagkos, Sotirios Tsalamandris, Ioannis Tsiafoutis, Konstantinos Katsanos, Konstantinos Toutouzas, Adel Aminian, Dimitrios Alexopoulos, Periklis Davlouros
Format: Article
Language:English
Published: MDPI AG 2023-02-01
Series:Life
Subjects:
dual antiplatelet therapy
DAPT
one-month DAPT
percutaneous coronary intervention
PCI
meta-analysis
Online Access:https://www.mdpi.com/2075-1729/13/3/666

Internet

https://www.mdpi.com/2075-1729/13/3/666

Similar Items